Brain Mapping of Language Impairments

Brain Mapping of Language ImpairmentsResearchers mapped different language impairments to specific brain regions to reveal the basic organization of our language system.

Drugs Lessen Multiple Sclerosis Damage in Mice

Drugs Lessen Multiple Sclerosis Damage in MiceIn a mouse study, 2 drugs already on the market activated stem cells and repaired the type of brain damage seen in multiple sclerosis. The finding might lead to novel therapies.

Laser beam compressed into thin filament

Scientists have been researching the process of laser pulse filamentation — the effect produced when a laser beam propagating in air focuses into a filament. The researchers discovered how this process influences the preliminary transition of a beam passing through quartz glass, which has applications in the field of nonlinear optics.

Hospital drill involves simulated medical helicopter crash

Southern New Hampshire Medical Center is conducting an emergency drill involving a simulated medical helicopter crash atop the hospital’s parking garage. The Telegraph of Nashua reports the test including teams from the city of Nashua and the hospital on Friday morning involves a scenario in which a Boston Med Flight copter has engine trouble during a hospital transfer, and crashes on the helipad.

Peregrine Pharmaceuticals Enters Into Research Collaboration to…

Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company focused on advancing bavituximab, a novel immuno-oncology agent in Phase III development for the treatment of lung cancer, today announced that the company has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center to explore the potential of Peregrine’s proprietary phosphatidylserine -targeting antibody platform. The goal of the research is to identify effective treatment combinations based on Peregrine’s PS-targeting agents, including Peregrine’s lead clinical agent bavituximab, with other checkpoint inhibitors or immune stimulating agents that will further guide the bavituximab clinical development program.